KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Peptide Partners: 61 Kovera certificates.
The lab's record shows 61 certificates printed for Peptide Partners, analysed between 25 Feb 2026 and 16 Jul 2026, covering 28 products. Median HPLC purity is 99.83%. Kovera graded 30 as a pass and 2 as a fail; 29 carry no verdict.
61
certificates
99.83%
median purity
28
products
2
lab verdict: fail
2
failure rules met
What the record shows
RETRIEVED 2 AUGUST 20262 of the 61 certificates meet at least one of our failure rules. They are shaded in the table below. 13 measured more than 110% of the label, which Kovera does not grade as a fail.
Kovera revised 2 of these certificates after first publication, under the same report number: KVR-2026-AB315B (revised by the lab 2026-06-20: purity 99.806% → 99.81%, content 11.86 → — mg); KVR-2026-667A00 (revised by the lab 2026-05-27, figures unchanged). Why that matters is in our revisions analysis.
We audit Peptide Partners separately from public records: read our Peptide Partners audit.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
28 AS PRINTEDCagrilintide · 3Retatrutide · 3BPC-157 · 2Epithalon · 2Semaglutide · 2Semax · 2Tirzepatide · 25-Amino-1MQ · 1AOD-9604 · 1Bacteriostatic Water · 1BPC-157/TB-500 · 1CJC-1295 (No DAC)/Ipamorelin · 1CJC-1295 no DAC · 1CJC-1295 no DAC/Ipamorelin/Tesamorelin · 1DSIP · 1GHK-Cu · 1Glow · 1Ipamorelin · 1Kisspeptin-10 · 1Klow · 1KPV · 1MOTS-c · 1Pinealon · 1PT-141 · 1Sermorelin · 1SS-31 · 1Tesamorelin · 1Thymosin alpha-1 · 1
Every certificate
NEWEST FIRST · 61 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-6108FD | Retatrutide | RTT2613 | 99.778% | 104.2%12.5 of 12 mg | 16 Jul 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-F8A885 | Kisspeptin-10 | KSS2607 | 99.713% | 113.1%11.31 of 10 mg | 2 Jul 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-28597D | PT-141 | PT202605 | 99.742% | 131.0%13.1 of 10 mg | 25 Jun 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-AB315B | 5-Amino-1MQ | AM202604 | 99.81% | 118.6%11.86 of 10 mg | 20 Jun 2026 | PASSover 110% of labelrevised by the lab 2026-06-20: purity 99.806% → 99.81%, content 11.86 → — mg | Kovera ↗our verifier → |
| KVR-2026-A7DC2C | Retatrutide | RTT202606 | 99.356% | 93.2%11.18 of 12 mg | 20 Jun 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-DD8FF8 | KPV | KV202606 | 99.705% | 106.9%10.69 of 10 mg | 10 Jun 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-D8F3B3 | Semaglutide | SM202607 | 99.687% | 119.8%11.98 of 10 mg | 10 Jun 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-AD226C | Ipamorelin | IP202606 | 99.711% | 131.8%13.18 of 10 mg | 10 Jun 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-479A0C | BPC-157 | BC202607 | 99.746% | 127.3%12.73 of 10 mg | 10 Jun 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-EB005D | Tirzepatide | TZ202605 | 99.552% | 103.4%41.36 of 40 mg | 9 Jun 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-CD3187 | Retatrutide | RT202607 | 99.765% | 105.8%25.4 of 24 mg | 9 Jun 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-B2021B | CJC-1295 no DAC | CJ202606 | 99.33% | 115.9%11.59 of 10 mg | 9 Jun 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| RSTER-KVR-2026-643CB5 | Semaglutiderapid sterility certificate | SM202607 | — | — | 24 May 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-6181C7 | BPC-157 | BC202606 | 99.894% | 107.2%10.72 of 10 mg | 17 May 2026 | PASS | Kovera ↗our verifier → |
| RSTER-KVR-2026-71F166 | Cagrilintiderapid sterility certificate | CG202607 | — | — | 15 May 2026 | NO VERDICT | Kovera ↗our verifier → |
| RSTER-KVR-2026-31845E | CJC-1295 (No DAC)/Ipamorelinrapid sterility certificate | CJIP202605 | — | — | 15 May 2026 | NO VERDICT | Kovera ↗our verifier → |
| HM-KVR-2026-71F166 | —heavy metals certificate | — | — | — | 15 May 2026 | NO VERDICT | Kovera ↗our verifier → |
| HM-KVR-2026-643CB5 | —heavy metals certificate | — | — | — | 15 May 2026 | NO VERDICT | Kovera ↗our verifier → |
| HM-KVR-2026-31845E | —heavy metals certificate | — | — | — | 15 May 2026 | NO VERDICT | Kovera ↗our verifier → |
| BAC-KVR-2026-CEFA2B | Bacteriostatic Waterbac water certificate | BAC202602 | — | — | 15 May 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-667A00 | Epithalon | ET202604 | 99.862% | 108.7%43.47 of 40 mg | 13 May 2026 | PASSrevised by the lab 2026-05-27, figures unchanged | Kovera ↗our verifier → |
| STER-KVR-2026-856D5C | —sterility certificate | — | — | — | 8 May 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-DC032B | CJC-1295 no DAC/Ipamorelin/Tesamorelin | CIT202604 | 99.794% | 105.9%42.37 of 40 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-02D521 | DSIP | DS202605 | 99.846% | 106.2%5.31 of 5 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| HM-KVR-2026-856D5C | —heavy metals certificate | — | — | — | 22 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-A01ED6 | Tesamorelin | TES202604 | 99.854% | 116.1%11.61 of 10 mg | 21 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-902ECB | Klow | KW202604 | 99.809% | 104.6%83.66 of 80 mg | 21 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-322ED2 | BPC-157/TB-500 | BB202605 | 99.946% | 110.2%22.03 of 20 mg | 21 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-803483 | AOD-9604 | AO202605 | 99.964% | 96.8%9.68 of 10 mg | 20 Apr 2026 | PASS | Kovera ↗our verifier → |
| ENDO-KVR-2026-18A622 | Cagrilintideendotoxin certificate | KVR-2026-18A622 | — | — | 20 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-18A622 | Cagrilintide | CG202603 | 99.951% | 98.4%9.84 of 10 mg | 14 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-030E88 | SS-31 | SS202601 | 99.912% | 117.3%11.73 of 10 mg | 10 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| HM-KVR-2026-EFD77F | —heavy metals certificate | — | — | — | 5 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| HM-KVR-2026-E51CD6 | —heavy metals certificate | — | — | — | 5 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| HM-KVR-2026-E3876B | —heavy metals certificate | — | — | — | 5 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| HM-KVR-2026-CF9EF1 | —heavy metals certificate | — | — | — | 5 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| HM-KVR-2026-CC3BED | —heavy metals certificate | — | — | — | 5 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| HM-KVR-2026-BCFDD3 | —heavy metals certificate | — | — | — | 5 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| HM-KVR-2026-A65D86 | —heavy metals certificate | — | — | — | 5 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| HM-KVR-2026-9258BA | —heavy metals certificate | — | — | — | 5 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| HM-KVR-2026-81222F | —heavy metals certificate | — | — | — | 5 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| HM-KVR-2026-62476E | —heavy metals certificate | — | — | — | 5 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| HM-KVR-2026-2E7D9C | —heavy metals certificate | — | — | — | 5 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| ENDO-KVR-2026-CC3BED | —endotoxin certificate | — | — | — | 5 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-1E8D20 | MOTS-c | MC202603 | 99.961% | 112.4%11.24 of 10 mg | 4 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B787A6 | GHK-Cu | CU202604 | 99.953% | 95.8%95.85 of 100 mg | 3 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-E72260 | Pinealon | PN202603 | 99.986% | 109.3%21.87 of 20 mg | 1 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-547DE8 | Sermorelin | SER202601 | 99.986% | 114.6%11.46 of 10 mg | 1 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-CAAD42 | Semax | SX202603 | 99.927% | 99.2%19.84 of 20 mg | 31 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-59E1F5 | Tirzepatide | TZ202603 | 99.988% | 108.6%43.44 of 40 mg | 26 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-6E0B96 | Glow | GW202603 | 99.791% | 108.1%75.66 of 70 mg | 25 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-1AF8EF | Semax | SX202603 | 99.933% | 68.7%20.62 of 30 mg | 24 Mar 2026 | faillab verdict: fail · under 90% of label | Kovera ↗our verifier → |
| HM-KVR-2026-83CA86 | —heavy metals certificate | — | — | — | 21 Mar 2026 | NO VERDICT | Kovera ↗our verifier → |
| ENDO-KVR-2026-83CA86 | —endotoxin certificate | — | — | — | 21 Mar 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-C06E75 | Epithalon | ET202604 | 72.846% | 109.4%10.94 of 10 mg | 20 Mar 2026 | faillab verdict: fail · purity under 95% | Kovera ↗our verifier → |
| HM-KVR-2026-301FB5 | —heavy metals certificate | — | — | — | 28 Feb 2026 | NO VERDICT | Kovera ↗our verifier → |
| ENDO-KVR-2026-9E35D5 | —endotoxin certificate | — | — | — | 28 Feb 2026 | NO VERDICT | Kovera ↗our verifier → |
| ENDO-KVR-2026-807832 | —endotoxin certificate | — | — | — | 28 Feb 2026 | NO VERDICT | Kovera ↗our verifier → |
| ENDO-KVR-2026-377645 | —endotoxin certificate | — | — | — | 28 Feb 2026 | NO VERDICT | Kovera ↗our verifier → |
| ENDO-KVR-2026-301FB5 | —endotoxin certificate | — | — | — | 28 Feb 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-9E35D5 | Thymosin alpha-1 | TA202602 | 99.952% | 128.4%12.84 of 10 mg | 25 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |